- Home
- LNTH vs QTWO Comparison
LNTH vs QTWO Comparison
Compare LNTH & QTWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LNTH | QTWO |
|---|---|---|
| Founded | 1956 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.7B |
| IPO Year | 2015 | 2014 |
Fundamental Metrics
Financial Performance| Metric | LNTH | QTWO |
|---|---|---|
| Price | $66.12 | $75.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 15 |
| Target Price | $77.33 | ★ $100.93 |
| AVG Volume (30 Days) | ★ 1.0M | 704.4K |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.39 | 0.51 |
| Revenue | ★ $1,525,933,000.00 | $769,632,000.00 |
| Revenue This Year | $0.01 | $15.92 |
| Revenue Next Year | $1.24 | $10.27 |
| P/E Ratio | ★ $27.84 | $148.90 |
| Revenue Growth | 1.95 | ★ 13.93 |
| 52 Week Low | $47.25 | $58.57 |
| 52 Week High | $111.29 | $108.51 |
Technical Indicators
Market Signals| Indicator | LNTH | QTWO |
|---|---|---|
| Relative Strength Index (RSI) | 72.55 | 64.84 |
| Support Level | $60.15 | $72.67 |
| Resistance Level | $64.40 | $74.08 |
| Average True Range (ATR) | 2.09 | 1.73 |
| MACD | 0.66 | 0.18 |
| Stochastic Oscillator | 94.44 | 83.18 |
Price Performance
Historical ComparisonAbout LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About QTWO Q2 Holdings Inc.
Q2 Holdings Inc. is a provider of cloud-based virtual banking solutions for regional financial institutions to deliver mobile banking services to retail and commercial end-users who wish to bank anywhere and anytime. Its solutions operate on an integrated tablet-first platform which provides financial institutions a comprehensive view of account holder activity and meets the regulatory and security requirements applicable to the industry. The firm generates revenue from subscription-based arrangements for software offerings. A large majority of the firm's revenue is generated in the United States.